Lucius Mirdametinib – Beli Online

IDR 9,749,250

800+ terjual
Harga Promo

Apotek fisik Hong Kong dengan jaminan produk asli 100%

Keunggulan Produk

(Mirdametinib) MEK1 MEK2 ,

Jaminan Layanan

Pengiriman Lintas NegaraApotek ResmiDitinjau ApotekerJaminan Keaslian

Spesifikasi

Spesifikasi
1mg*42 capsules/box
Produsen
Lucius Pharmaceuticals
Pengiriman
Hong Kong

Stok 10000

Kategori: Brand:

Informasi Produk

Nama Inggris
Mirdametinib
Nama Generik
Mirdametinib

Spesifikasi

Spesifikasi
1mg*42 capsules/box
Produsen
Lucius Pharmaceuticals
Pengiriman
Hong Kong

Rincian Lengkap

Indikasi

Mirdametinib is the first and only therapy approved in the European Union for adults and children 2 years of age and older with neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN).

Mekanisme Kerja

Mirdametinib Mekanisme Kerja Mekanisme Kerja ,

Dosis dan Penggunaan

2 GOMEKLI 2 mg/m², , , 28 21 GOMEKLI (2) 2.1 GOMEKLI GOMEKLI [ Peringatan (5.1)] (EF)[ Peringatan (5.2)] 2.2 GOMEKLI GOMEKLI GOMEKLI ,

Peringatan

5 Peringatan GOMEKLI , , , , GOMEKLI (5.1) GOMEKLI , , 3 , GOMEKLI (5.2) , , GOMEKLI

Package Insert

Ingredients

11 GOMEKLI (R)-N-(2,3- )-3,4- -2-((2- -4- ) ) C16H14F3IN2O4, 482.20 g/mol , 25°C 0.25 mg/mL,pH 7.2 pKa 7.96

Indications

Mirdametinib is the first and only therapy approved in the European Union for adults and children 2 years of age and older with neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN).

Dosis dan Penggunaan

2 GOMEKLI 2 mg/m², , , 28 21 GOMEKLI (2) 2.1 GOMEKLI GOMEKLI [ Peringatan (5.1)] (EF)[ Peringatan (5.2)] 2.2 GOMEKLI GOMEKLI GOMEKLI ,

Precautions

5 Peringatan GOMEKLI , , , , GOMEKLI (5.1) GOMEKLI , , 3 , GOMEKLI (5.2) , , GOMEKLI

Use in Pregnancy and Lactation

8.1 Mekanisme Kerja[ (12.1)] ,GOMEKLI - , mirdametinib, - , (BSA) 2 mg/m², , 2% 4% 15% 20%

Clinical Pharmacology

12 12.1 Mekanisme Kerja 1 2 (MEK1/2) MEK1/2 (ERK) , MEK1 MEK2 ERK NF1 , ERK , 12.2 -

Pharmacology and Toxicology

13 13.1 6 rasH2 , 5 mg/kg AUC , 2 mg/m² 15 Ames , 1 , 28

Clinical Studies

6.1 , , Peringatan Description ReNeu [ (14)] n=114 NF-106 n=19 [NCT-02096471] 133 75 58 GOMEKLI 28 21 GOMEKLI 2 mg/m², , GOMEKLI 133 ,62% ,38% ,12%

Ulasan Produk (17)

Filter: All Reviews
4.8★★★★★
+o***e· 3周前
★★★★
+t***3· 1个月前
Pembelian Terverifikasi
★★★★★

Deskripsi produk

Indikasi

Mirdametinib is the first and only therapy approved in the European Union for adults and children 2 years of age and older with neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN).

Mekanisme Kerja

Mirdametinib Mekanisme Kerja Mekanisme Kerja ,

Dosis dan Penggunaan

2 GOMEKLI 2 mg/m², , , 28 21 GOMEKLI (2) 2.1 GOMEKLI GOMEKLI [ Peringatan (5.1)] (EF)[ Peringatan (5.2)] 2.2 GOMEKLI GOMEKLI GOMEKLI ,

Peringatan

5 Peringatan GOMEKLI , , , , GOMEKLI (5.1) GOMEKLI , , 3 , GOMEKLI (5.2) , , GOMEKLI